This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month
Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock soared.
Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock soared.
Oil falls despite fresh attacks on Saudi energy infrastructure !“#$%&‘()*+,–./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|} !“#$%&‘()*+,–./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}
Goldman Sachs aims to ensure that new artificial intelligence tools don’t lead to a loss of knowledge within the institution, Chris Churchman, head of the company’s digital platform for institutional clients, Marquee, said, CNBC reported Monday (Aug. 24). Speaking during an episode of Goldman Sachs’ podcast, Exchanges, Churchman said an overreliance on AI could lead…
Wall Street goes through cycles. One that recurs with some regularity is the shift between conglomeration and corporate separations. Right now, conglomerates are separating, creating multiple businesses from one. Honeywell is a good example of this trend, with the conglomerate breaking into Honeywell Technologies (HON +0.95%), Solstice Advanced Materials (SOLS +3.85%), and Honeywell Aerospace (HONA…
The Bank of England’s Monetary Policy Committee (MPC) has voted to hold the base rate at 3.75%. In July, the hold at 3.75% was the fifth consecutive hold since the base rate was first cut to this figure in December last year. Since then, geopolitical uncertainty surrounding the US-Iran conflict has thrown the market…
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
Axis has assigned a target price of Rs 1,000, implying an upside of 19% from current market levels. It is a leading owner, developer, and asset manager of high-end hotels in India, primarily operating in key metro cities such as Mumbai, Hyderabad, Bengaluru, and Pune. The company’s portfolio comprises luxury and upper upscale hotels managed…